… to add new drugs if one or more drugs are withdrawn … anti-tuberculosis drugs, they may
discontinue treatment unnecessarily, re-introduce drugs with suboptimal timing, add new drugs …

… It has been estimated that in Spain anti-tuberculosis drugs … with hepatotoxicity due to
antituberculosis drugs are varied: … anti-tuberculosis drugs, association with other hepatotoxic …

… to be effective against antituberculosis drug-resistant strains. … about eight new antituberculosis
drug candidates and describes … of drug-resistance induced by these drug candidates. …

… -TB drugs may lead to the development of multidrug resistant and extensively drug resistant
TB… anti-TB drugs is further exacerbated by co-morbidities such as HIV infection and diabetes. …

In the present study, the biochemical manifestations of liver toxicity caused by co-administration
of anti-TB drugs, rifampicin (RIF), isoniazid (INH) and pyrazinamide (PZA), in a sub-…

… of anti-tuberculosis drug resistance has been shaped by the history of development of
anti-tuberculosis drugs … Drug resistance in Mycobacterium tuberculosis was shown to be related to …

… to address bottlenecks in drug development, drug repurposing of approved drugs is being
… Drug-repurposing strategies can be used to identify new anti-TB drug candidates that have …

… to anti-tuberculosis (anti-TB) drug therapy. Objectives To assess the incidence and severity
of adverse drug reactions (ADRs) induced by anti-TB drugs… anti-TB drugs during the research …

… measures and the increase of drug-resistant M. tuberculosis … targets for the development
of new drugs to treat TB. This … be potentially explored towards selective drug development. …

… are recognized as targets for the anti-tuberculosis drug ethambutol. In this study… Most
drug-resistant mutations are located near the … and the development of new anti-tuberculosis …